Innopolis announces results of the AI International Hakathon Global AI Challenge

As many as 90 teams from 15 countries took part in AI International Hakathon Global AI Challenge organized by the AI Research Center of the Innopolis University in Tatarstan. According to the results of the competition, the ClosedAI team from Moscow took the first place, the Gradient Kekpointing from Skolkovo was the second and DrugANNs from Msocow and Semyons, comprising developers from St. Petersburg and Vienna divided the third place.

Speaking at the awarding ceremony of the competition, Russian Deputy Head of the Government Dmitriy Chernyshenko said: “I am very pleased that Russian developers have become winners of the Global AI Challenge. They not only demonstrated outstanding work but also made a contribution into digitalization of economy of the country. In its turn, the Government will also help the presented solutions to find use in practice including implementation of the AI federal project”.

Tatarstan President Rustam Minnikhanov, who also took part in the ceremony, said that international competitions in AI are very important for development of the technological potential of the country.

“AI helps us to improve life quality of people. It is not limited only to voice assistant for long time already. Today is it used for diagnostics by medical doctors, for analysis in the financial sphere and to control the transport. Various AI implementations are actively studied in the Innopolis University and on the example of this hakathon we can see how projects by young scientists in AI make a substantial contribution not only into the development of advanced technologies but into modern medicine” for example”, he said.

Director of the AI Institute of the Innopolis University Ramil Kuleyev said: “Participants of the hakathon developed models for SARS CoV2 screening on the basis of small molecules. These models can be used for developing medications against Corona and the proposed solutions – for developing medications for various diseases”.